Search Videos and More
Document
Expert Review: Communicating Risk and Uncertainty in the Context of Genomic Testing
The Breast Oncology Center developed this reference for providers based on a presentation by Professor Dame Lesley Fallowfield given on October 23, 2024.
Document
Tip Sheet: QTc Monitoring in Breast Cancer Patients
The Breast Oncology Center developed this reference for QTc monitoring for breast cancer patients based on a presentation given on October 16, 2024, by Anju Nohria, MD, MSc, director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center
Document
Tip Sheet: Adrenal Insufficiency in Breast Cancer Patients
The Breast Oncology Center developed this reference for providers treating breast cancer patients with adrenal insufficiency in July 2025.
News
Dana-Farber Research News 10.01.2025
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from September 1 through September 15.
News
Cracking the Code
It was 2014 and Filbin was a hematology/oncology fellow specializing in pediatric brain cancer. Her mentor, David Williams, MD, now associate chair of Pediatric Oncology at Dana-Farber, wanted her to go to a lab at the Massachusetts Institute of Technology (MIT) for the research portion of her fellowship.
News
New Diagnostic Tool Developed at Dana-Farber Revolutionizes Acute Leukemia Diagnosis
Researchers at Dana-Farber Cancer Institute have developed a groundbreaking diagnostic tool that could transform the way acute leukemia is identified and treated.
Document
AACR Pediatric Special Conference in Cancer Research
September 25 - 28, 2025, Boston, MA
News
Dana-Farber Research News 09.15.2025
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 16 - August 31.
News
Dana-Farber Treats First Patient with Approved Gene Therapy for Beta Thalassemia
A few years ago, Oscar Diep, a 33-year-old software engineer living in Weymouth, Mass., started needing blood transfusions more often to manage a blood disorder called beta thalassemia.
News
Dana-Farber Research News 09.01.2025
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 1 - August 15.
News
Clinical Trials and Research for Mantle Cell Lymphoma
Dana-Farber Cancer Institute is at the forefront of research in mantle cell lymphoma. We seek to advance more effective treatment options and reduce treatment side effects for patients with mantle cell lymphoma.
Course
Stem Cell Transplant and Cellular Therapies Symposium 2025
Enhance your ability to manage capacity effectively by gaining essential knowledge and strategies to streamline care and improve outcomes for patients undergoing stem cell transplants or CAR T-cell therapies.